Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
Tags:
AbbVie, Rinvoq, Regeneron, Sanofi, Dupixent, atopic dermatitis
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
BioSpace
Thu, 04/25/24 - 05:56 pm
Tags:
Sanofi, AstraZeneca
Sanofi profit slips on generic competition and currency effects
Reuters
Thu, 04/25/24 - 05:47 pm
Tags:
Sanofi, earnings, generics
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Clinical Trials Arena
Tue, 04/23/24 - 10:51 am
Tags:
Sanofi, rilzabrutinib, Btk inhibitors, ITP
Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg
Fierce Pharma
Mon, 04/22/24 - 05:59 pm
Tags:
Sanofi, legal, Zantac, settlements
Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group
Fierce Pharma
Thu, 04/18/24 - 10:30 pm
Tags:
Sanofi, restructuring, vaccines
IGM and Sanofi collaboration will pivot to immunology and inflammation
Pharmaceutical Technology
Wed, 04/17/24 - 10:09 pm
Tags:
Sanofi, IGM Biosciences, immunology, inflammation
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
BioSpace
Thu, 04/11/24 - 10:22 pm
Tags:
biotech, layoffs, Genentech, Sanofi, Novartis
Sanofi begins 'full pipeline reprioritization' with layoffs in tow, R&D chief tells staff
Fierce Biotech
Fri, 04/5/24 - 11:26 am
Tags:
Sanofi, R&D, layoffs
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
Reuters
Wed, 04/3/24 - 10:25 pm
Tags:
Sanofi, Zantac, cancer, legal
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024
BioSpace
Wed, 03/27/24 - 11:06 am
Tags:
COPD, Sanofi, Regeneron, Verona Pharma, Dupixent, ensifentrine
After decades of waiting, late-stage therapies may penetrate the COPD market this year
Clinical Trials Arena
Sun, 03/24/24 - 10:31 pm
Tags:
COPD, drug development, Sanofi, Regeneron, Dupixent, Verona, ensifentrine
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Tags:
Incyte, clinical trials, prurigo nodularis, povorcitinib, Dupixent, Sanofi, Regeneron
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Tags:
Sanofi, AstraZeneca, Beyfortus, RSV, monoclonal antibodies
With Sanofi left as the lone supplier of tetanus shots in the US, CDC warns of shortage
Fierce Pharma
Fri, 03/1/24 - 11:50 am
Tags:
CDC, Sanofi, tetanus, vaccines, drug shortages
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Tags:
Takeda, Eohilia, Sanofi, Dupixent, EoE, eosinophilic esophagitis
Sanofi CEO Hudson takes another small dip in pay to €10.57M
Fierce Pharma
Mon, 02/26/24 - 05:15 pm
Tags:
Sanofi, Pharma CEOs, Paul Hudson, executive compensation
Sanofi looks to advance CSU drug rilzabrutinib in Phase III trial
Clinical Trials Arena
Mon, 02/26/24 - 10:35 am
Tags:
Sanofi, rilzabrutinib, chronic spontaneous urticaria, clinical trials
Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
BioSpace
Fri, 02/23/24 - 10:43 am
Tags:
FDA, Sanofi, Regeneron, Dupixent, priority review, COPD
Sanofi's planned consumer health spinoff picks up interest from multiple firms
Fierce Pharma
Wed, 02/21/24 - 10:35 pm
Tags:
Sanofi, consumer healthcare, spinoffs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.